The effects of cyclosporin and prednisone on plasma lipid and lipoprotein levels were studied in 20 allogeneic bone-marrow transplantation patients receiving cyclosporin plus prednisone therapy, and in 14 allogeneic patients treated only with cyclosporin during 100 days. Eighteen autologous bone-mar
Effect of cyclosporin on plasma lipoprotein lipase activity in rats
✍ Scribed by Jose López-Miranda; Francisco Pérez-Jiménez; Juan A. Gómez-Gerique; Antonio Espino-Montoro; Luis Hidalgo-Rojas; Javier Pedreño; Jose A. Jiménez-Perepérez
- Publisher
- Elsevier Science
- Year
- 1992
- Tongue
- English
- Weight
- 576 KB
- Volume
- 25
- Category
- Article
- ISSN
- 0009-9120
No coin nor oath required. For personal study only.
✦ Synopsis
The effects of cyclosporin on plasma lipoproteins and lipoprotein lipase (LPL) activity were studied in rats treated with different doses of the drug for periods ranging between 7 and 30 days. The treatment with cyclosporin resulted in an increase in plasma triglycerides and non-HDL-cholesterol, and a dose and time-dependent decrease of LPL activity and HDL-cholesterol, mainly because of a fall in the HDL2-cholesterol subfraction. The decrease of LPL activity was positively correlated (p < 0.01 ) with plasma HDL-cholesterol and HDL2-cholesterol and negatively with plasma triglycerides and non-HDL-cholesterol (p < 0.01).
Our results indicate that the decrease in plasma LPL activity may be responsible for the increase in plasma triglycerides and the decrease in plasma HDL-cholesterol found in rats under cyclosporin treatment.
📜 SIMILAR VOLUMES
Heparin possesses a dual biological function in preventing blood coagulation. It forms complexes with antithrombin III' and apolipoprotein C-112-", of which the latter releases lipoprotein lipase (LPL, EC 3.1.1.3) into the circulating blood. LPLreleasing activity has also been observed with some gly
## Abstract The response of cyclosporine A (CyA) blood concentrations following changes in lipoprotein levels have been inconsistent. Some studies show increases in concentrations, whereas others have shown decreases. The intent of this study was to examine the effect of two rat models of increased
Both glucocorticoids and cyclosporine are used to prevent rejection in organ transplant recipients. However, long-term treatment with these drugs is known to induce hyperlipidemia and premature development of atherosclerosis. In previous studies, we have shown that the immunosuppressive drug cyclosp